Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of success from a randomized trial.
Sign Up to like & getrecommendations! Published in 2020 at "American journal of obstetrics and gynecology"
DOI: 10.1016/j.ajog.2020.04.006
Abstract: BACKGROUND Early pregnancy loss (EPL) is a common event in the first trimester, occurring in 15-20% of recognized pregnancies. A common evidence-based medical regimen for EPL management uses the prostaglandin E1 analogue misoprostol 800 mcg… read more here.
Keywords: success; mifepristone misoprostol; treatment; pregnancy ... See more keywords
Feasibility of assessing the safety and effectiveness of menstrual regulation medications purchased from pharmacies in Bangladesh: a prospective cohort study.
Sign Up to like & getrecommendations! Published in 2018 at "Contraception"
DOI: 10.1016/j.contraception.2017.08.002
Abstract: OBJECTIVE To assess the feasibility of following up women who purchase mifepristone+misoprostol or misoprostol-only from pharmacies in order to measure the safety and effectiveness of self-administration of menstrual regulation. STUDY DESIGN A prospective cohort study… read more here.
Keywords: mifepristone misoprostol; methodology; study; misoprostol ... See more keywords
Provision of menstrual regulation with medication among pharmacies in three municipal districts of Bangladesh: a situation analysis.
Sign Up to like & getrecommendations! Published in 2018 at "Contraception"
DOI: 10.1016/j.contraception.2017.11.006
Abstract: OBJECTIVE The objective was to assess the provision of the combination of mifepristone-misoprostol for menstrual regulation (MR) in randomly selected urban pharmacies in Bangladesh. STUDY DESIGN We conducted a cross-sectional survey among 553 pharmacy workers… read more here.
Keywords: mifepristone misoprostol; combination; pharmacy workers; municipal districts ... See more keywords
A cross-sectional analysis of mifepristone, misoprostol, and combination mifepristone-misoprostol package inserts obtained in 20 countries.
Sign Up to like & getrecommendations! Published in 2020 at "Contraception"
DOI: 10.1016/j.contraception.2020.01.011
Abstract: OBJECTIVES To evaluate the characteristics, clinical information, and storage instructions contained in package inserts from medical abortion commodities collected in low- and middle-income countries. STUDY DESIGN From November 2017 to February 2018 mifepristone, misoprostol, and… read more here.
Keywords: mifepristone misoprostol; mifepristone; medical abortion; package inserts ... See more keywords
Systematic Review of the Effectiveness, Safety, and Acceptability of Mifepristone and Misoprostol for Medical Abortion in Low- and Middle-Income Countries.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC"
DOI: 10.1016/j.jogc.2020.04.006
Abstract: OBJECTIVE Abortion-related complications remain one of the leading causes of maternal morbidity and mortality worldwide. Nearly half of all abortions are unsafe, and the vast majority of these occur in low- and middle-income countries. The… read more here.
Keywords: mifepristone misoprostol; abortion; low middle; medical abortion ... See more keywords
Medical termination for pregnancy in early first trimester (≤ 63 days) using combination of mifepristone and misoprostol or misoprostol alone: a systematic review
Sign Up to like & getrecommendations! Published in 2020 at "BMC Women's Health"
DOI: 10.1186/s12905-020-01003-8
Abstract: Background A wide range of drugs have been studied for first trimester medical abortion. Studies evaluating different regimens, including combination mifepristone and misoprostol and misoprostol alone regimens, show varying results related to safety, efficacy and… read more here.
Keywords: mifepristone misoprostol; abortion; combination; misoprostol alone ... See more keywords
Economic evaluation of a randomized controlled trial comparing mifepristone and misoprostol with misoprostol alone in the treatment of early pregnancy loss
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0262894
Abstract: Background In case of early pregnancy loss (EPL) women can either choose for expectant, medical or surgical management. One week of expectant management is known to lead to spontaneous abortion in approximately 50% of women.… read more here.
Keywords: misoprostol alone; misoprostol; trial; mifepristone misoprostol ... See more keywords
Short-Term Adverse Outcomes After Mifepristone–Misoprostol Versus Procedural Induced Abortion
Sign Up to like & getrecommendations! Published in 2023 at "Annals of Internal Medicine"
DOI: 10.7326/m22-2568
Abstract: BACKGROUND Prior studies comparing first-trimester pharmaceutical induced abortion (IA) with procedural IA were prone to selection bias, were underpowered to assess serious adverse events (SAEs), and did not account for confounding by indication. Starting in… read more here.
Keywords: mifepristone misoprostol; adverse outcomes; per 1000; short term ... See more keywords